Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2004-01-30
2010-02-02
Moore, Susanna (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C514S265100, C514S300000, C546S118000, C546S113000
Reexamination Certificate
active
07655795
ABSTRACT:
The present invention relates to a new process for the preparation of compounds of general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH). The present invention relates to a new process for the preparation of compounds of general formula (I) which are inhibitors of purine nucleoside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5′-methylthioadenosine phosphorylases (MTAP), 5′-methylthioadenosine nucleosidases (MTAN) and/or nucleoside hydrolases (NH).
REFERENCES:
patent: 5985848 (1999-11-01), Furneaux et al.
patent: 6066722 (2000-05-01), Furneaux et al.
patent: 6228847 (2001-05-01), Furneaux et al.
patent: 6379911 (2002-04-01), Schramm et al.
patent: 6458799 (2002-10-01), Montgomery et al.
patent: 6492347 (2002-12-01), Furneaux et al.
patent: 6693193 (2004-02-01), Furneaux et al.
patent: 6764829 (2004-07-01), Schramm et al.
patent: 6803455 (2004-10-01), Furneaux et al.
patent: 7022852 (2006-04-01), Furneaux et al.
patent: 7098334 (2006-08-01), Furneaux et al.
patent: 7109331 (2006-09-01), Furneaux et al.
patent: 7211653 (2007-05-01), Furneaux et al.
patent: 7211677 (2007-05-01), Furneaux et al.
patent: 2006/0160765 (2006-07-01), Evans et al.
patent: WO 2005/118532 (2005-12-01), None
patent: WO 2006/014913 (2006-02-01), None
patent: WO 2006/123953 (2006-11-01), None
patent: WO 2007/069923 (2007-06-01), None
patent: WO 2007/097647 (2007-08-01), None
patent: WO 2007/097648 (2007-08-01), None
Karlsson S et al., entitled “Synthesis of enantiomerically pure 4-substituted pyrrolidin-3-ols via asymmetric 1,3-dipolar cycloaddition,” Tetrahedron: Asymmetry 12 (2001) 1977-1982.
Filichev V V et al., entitled “Synthesis of 1′-aza-C-nucleosides from (3R,4R)-4-(hydroxymethyl)pyrrolidin-3-ol,” Tetrahedron 57 (2001) 9163-9168.
Kamath V P et al., entitled “Synthesis of a potent transition-state inhibitor of 5′-Deoxy-5′-methylthioadenosine phosphorylase,” J. Med. Chem. 2004, 47, 1322-1324.
Lewandowicz A et al., entitled “Over-the barrier transition state analoques and crystal structure with Mycobacterium tubersulosis purine nucleoside phosphorylase,” Biochemistry 2003, 42, 6057-6066.
Evans G B et al., entitled “Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase,” J. Med. Chem. 2003, 46, 3412-3423.
Wolff M E, entitled “Burger's Medicinal Chemistry and Drug Discovery,” Fifth Edition, vol. 1: Principles and Practice, John Wiley & Sons, 1995, 975-977.
Banker G S et al., entitled “Modern Pharmaceutics,” Marcel Dekker Inc., Third Edition, Revised and Expanded, 1996, pp. 451 & 596.
“Biocryst Pharmaceuticals, Inc. Announces Preliminary Phase II Trial Data for a Topical Ointment formulation of PNP Drug Drug Candidate, BCX-34” Biocryst News, Apr. 29, 1998.
International Searching Authority, “Written Opinion of the International Searching Authority,” for International Application No. PCT/NZ2004/000017, 3 pages, Date of mailing: May 7, 2004.
“International Preliminary Report on Patentability,” for International Application No. PCT/NZ2004/000017, 3 pages, Date of completion: Jan. 18, 2005.
Evans G B et al. “Synthesis of a transition state analogue inhibitor of purine nucleoside phosphorylase via the Mannich reaction,” Organic Letters 2003, 5(20), 3639-3640.
Modnikova et al., Pyrrolo[3,2-d]pyrimidines. III. 7-Aminomethyl-substituted pyrrolo [3,2-d]pyrimidines, Khimiko-Farmasevticheskii Zjurnal, vol. 16, 1982, pp. 548-552.
Supplementary European Search Report dated May 27, 2009 from the European Patent Office in connection with European Patent Application No. 04706902.6, 2 pages.
Brakta M et al, entitled “Efficient Synthesis of 3H,5H-Pyrrolo[3,2-d] pyrimidin-4-one,” J. Chem. Soc. Perkin Trans., 1992, vol. 1, pp. 1883-1884.
Galeazzi, R et al., “Chiral 3-hydroxypyrrolidin-2-ones from a Baylis-Hillman adduct: convergent, stereoselective synthesis of glycosidase inhibitor,” Tetrahedron: Asymmetry, vol. 15, pp. 3249-3256, 2004.
Kametani, T et al, “Studies on the Syntheses of Heterocylic Compounds. 762. Synthesis of 3-benzyl-6-methyl-2-oxo-3,6-diazabicyclo[3.1.0]hexane as a synthetic intermediate of mitomycins,” Tetrahedron, 1979, 35(3), pp. 313-316.
Lewandowicz A et al. “Energetic Mapping of Transition State Analogue Internations with Human and Plasmodium falciparum Purine Nucleotide Phosphorylases” Journal of Biological Chemistry, 2005, 280(34), 30320-30328.
Lim M-I et al., entitled “A New Synthesis of Pyrrolo[3,2-d]pyrimidines (“9-Deazapurines”) via 3-Amino-2-carboalkoxypyrroles,” J. Org. Chem., 1979, vol. 44, No. 22, pp. 3826-3829.
STN FILE CA abstract No. 91-123648 (4 pages), downloaded, Jan. 4, 2006.
Miles R W et al., entitled “One-Third-the-Sites Transition-State Inhibitors for Purine Nucleoside Phosphorylase,” Biochemistry, 1998, vol. 37, No. 24, pp. 6-12.
Taylor E C et al., entitled “An Expeditious Synthesis of 2-Amino-4(3H)-oxo-5H-pyrrolo[3,2-d] pyrimidine (9-Deazaguanine),” Tetrahedron Letters, 1993, vol. 34, No. 29, pp. 4595-4598.
Evans Gary Brian
Tyler Peter Charles
Amster Rothstein & Ebenstein LLP
Industrial Research Limited
Moore Susanna
LandOfFree
Process for preparing pyrrolo[3,2-d]pyrimidine inhibitors of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing pyrrolo[3,2-d]pyrimidine inhibitors of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing pyrrolo[3,2-d]pyrimidine inhibitors of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201340